Phoenix Neurological Associates, Ltd.
5090 N. 40th Street
Suite 250
Phoenix, AZ 85018

Phone: (602) 258-3354
Fax: (602) 258-3368

email Phoenix Neurological Associates (If you have an urgent medical issue, do not email; please call us instead.)

news

January 2013: New publications by our physicians and staff. Read more


Share |


PNA Publishes New Research

Miravalle A, Hendin BA, Vollmer T, Kala M. Glatiramer acetate in the reduction of relapse frequency in multiple sclerosis. Clinical Medicine Insights: Therapeutics 2011:3 151-158.

Svennigsson A, Hendin BA. Clinical, biochemical and imaging parameters that may be predictive of high disease activity, rapid progression or increased disability in multiple sclerosis. Citation European Neurological Review 2012:7 (Supplement 2)

Saperstein D, Levine T, Levine M, Hank N. Usefulness of Skin Biopsies in the Evaluation and Management of Patients with Suspected Small Fiber Neuropathy. International Journal of Neuroscience, 123, 38-41, 2013

Clarke, Kathie and Levine, Todd. Clinical recognition and management of amyotrophic lateral sclerosis. J Neurosci Nurs. 2011. Aug (4). 205-214.

T. D. Levine, K.Van Keuren-Jensen, R. Bowser, N. C. Hank, S. Gately, D. Stephan,and D.S. Saperstein A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression, Neurology Research International Vol 12, 2012

Todd Levine: Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series. Drug Design, Development and Therapy Vol 6, 2012